Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease
Respirology2014Vol. 19(8), pp. 1215–1221
Citations Over TimeTop 10% of 2014 papers
Anne E. Holland, Julio F. Fiore, Emily C. Bell, Nicole Goh, Glen Westall, Karen Symons, Leona Dowman, Ian Glaspole
Abstract
Anxiety and depression are present in a significant minority of individuals with ILD. Dyspnoea and comorbidities are important contributors that may be amenable to intervention.
Related Papers
- → Comorbidity in head and neck cancer: A critical appraisal and recommendations for practice(2010)238 cited
- → Assessing the impact of comorbidity in the older population(1996)226 cited
- → Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival(2005)66 cited
- → Health Care Resource Utilization And Costs Associated With HIV-Positive Patients With Comorbidity Versus HIV-Negative Patients With Comorbidity(2017)4 cited
- Influence of comorbidity on the choice of treatment and survival of elderly patients with advanced non-small cell lung cancer(2008)